Fresh analysis suggests that individuals who come off popular GLP-1 drugs like Mounjaro or Wegovy may regain lost weight at a significantly accelerated pace than those who halt traditional diet and exercise plans.
Published data in a leading medical journal points out that while overweight individuals frequently drop a large proportion of their total mass while using the jabs, the weight comes back at an average rate of nearly a kilo each month once they quit.
"People using these medications need to be cognizant of the risk of fast rebound weight gain when the treatment is stopped," warns expert Dr. Susan Jebb.
Such speed of regain implies a reversion to pre-treatment mass in about 18 months.
Comparing Treatments
The study, which looked at dozens of trials involving thousands of patients, contrasted the effects of these new drugs with older methods.
Researchers note that people who shed pounds through lifestyle changes alone typically see a slower creep back—approximately 0.1 kg a month—after stopping.
Explaining the Fast Regain
Nutrition scientists suggest the mode of action of the injections is key to understanding the accelerated regain.
GLP-1 drugs copy a body's own chemical called GLP-1, which controls feelings of fullness.
"Artificially providing the hormone concentrations several times higher than normal might result in the body to produce less of its endogenous hormone, and may also lessen responsiveness to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement means hunger is no longer kept in check, making binge eating far more likely."
A Chronic Disease?
Medical guidelines suggest the injections for people with weight-linked health risks, alongside recommended diet and exercise modifications.
A number of clinicians contend that, considering the high risk of weight regain, the treatment might need to be ongoing.
This perspective is echoed by pharmaceutical companies, who say that the results "emphasize the chronic character of obesity," comparing it to managing diseases like high blood pressure.
User Testimonies
Individuals who have discontinued the medication report a intense resurgence of cravings.
"It was like a trigger that goes on and you become extremely hungry," described one woman.
This challenge is compounded if patients have not developed lasting lifestyle or habit modifications during treatment.
Significant Adoption
Survey data indicate that a significant number of adults in the UK have used these injections in the last 12 months, with demand remaining high.
- Use is greater among females than males.
- The 40s and 50s age group shows the greatest level of interest.
- Many obtain the drugs through private prescriptions rather than the NHS.
Ultimately, clinicians caution that while these medications are potent tools for weight loss, they are not a magic cure and long-term success likely depends on ongoing behavioural support.
